• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 023 Publication Date: 05/05/2010 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 7-209: CLSI POCT 05-A, Performance Metrics for Continuous Interstitial Glucose Monitoring. (InVitro Diagnostics)

Date of Standard: 2008. 
Address of Standards Organization:
  Clinical Laboratory Standards Institute (CLSI)
  950 West Valley Road
  Suite 2500
  Wayne, PA 19087
 
CDRH Office and Division Associated with Recognized Standards:
Devices Affected:
Continuous Glucose Monitoring Systems
Processes Affected:
PMA, IDE
Type of Standard:
 National, Vertical
Extent of Recognition:
Complete standard
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
Unclassified Sensor, Glucose, Invasive Class 3 MDS
 
Relevant Guidance:
There is no relevant guidance developed at this time.
FDA Technical Contact:
  Patricia Bernhardt
  FDA/CDRH/OIVD
  10903 New Hampshire Avenue Building 66, Room 5654
  Silver Spring MD 20993
  301/796-6136
  Email: patricia.bernhardt@fda.hhs.gov
-
-